NCT05624918 2026-04-08A Study of NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic AdenocarcinomaBig Ten Cancer Research ConsortiumPhase 2 Recruiting38 enrolled